Table 3.
Pathway | Permutation P Value |
---|---|
GM-CSF signaling | 0.0003 |
Integrin signaling | 0.0005 |
Role of macrophages fibroblasts and endothelial cells in rheumatoid arthritis | 0.0006 |
Chronic myeloid leukemia signaling | 0.0007 |
Germ cell–Sertoli cell junction signaling | 0.002 |
Growth hormone signaling | 0.002 |
NRF2-mediated oxidative stress response | 0.002 |
Pancreatic-adenocarcinoma signaling | 0.003 |
Virus entry via endocytic pathways | 0.003 |
Hereditary breast cancer signaling | 0.004 |
IGF-1 signaling | 0.004 |
Paxillin signaling | 0.005 |
FAK signaling | 0.006 |
Glucocorticoid receptor signaling | 0.006 |
MSP-RON signaling pathway | 0.007 |
T-cell receptor signaling | 0.007 |
Cardiac hypertrophy signaling | 0.007 |
PKC-θ signaling in T lymphocytes | 0.007 |
ErbB2-ErbB3 signaling | 0.008 |
Regulation of eIF4 and p70S6K signaling | 0.009 |
Leukocyte extravasation signaling | 0.009 |
Telomerase signaling | 0.01 |
Role of JAK1 and JAK3 in γc cytokine signaling | 0.01 |
Abbreviations: eIF4, eukaryotic initiation factor-4; ErbB2-ErbB3, epidermal growth factor receptor tyrosine kinase B2 and B3; FAK, focal adhesion kinase; GM-CSF, granulocyte-macrophage colony-stimulating factor; IGF-1, insulin-like growth factor 1; JAK, ribosomal protein S6 kinase (p70S6K), Janus kinase; MSP-RON, macrophage-stimulating protein-protein tyrosine kinase/receptor d’origine nantais; NRF2, nuclear factor erythroid 2-related factor; p70S6K, ribosomal protein S6 kinase; PKC-θ, protein kinase C-θ.